Remove Accountability Remove Healthcare Improvement Remove Life Sciences Remove Pharmaceuticals
article thumbnail

Insights Management: A New Paradigm for Cancer Treatment

HIT Consultant

Lance Hill, CEO of Within3 The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027 , life science companies are aligning efforts to prioritize this critical market opportunity ahead of competitors.